Repligen | RGEN - 流动负债

金融业

USD

USD 2.95B

现金及等价物

USD 566.02M

USD 94.08M

USD 1.14B

USD 135.83M

USD 542.21M

USD 19.97M

USD 39.54M

1.78K

EPS每股收益

USD 0.49

股本和储备

USD 2.11B

USD 103.83M

债务利息支出

USD 5.5M

USD 7.31M

USD 542.21M

USD 6.57B

USD 13.29M

USD 177.95M

USD 19.97M

普通股股本

USD 56.33M

164.06

USD 17.11M

USD 197.91M

销售和管理费用

USD 74.36M

USD 170.46M

贸易债权人

USD 30.01M

应收帐款人

USD 158.59M

	流动负债	更改		日
Agilent	USD 2.23B		113M	2025-12
Align Technology	USD 1.92B		46.45M	2025-12
Bio Techne	USD 140.43M		4.12M	2025-12
BioMarin Pharmaceutical	USD 759.03M		39.41M	2025-12
Bristol-Myers Squibb	USD 28.14B		608M	2025-09
Bruker	USD 1.28B		11.1M	2025-12
Charles River Laboratories	USD 1.12B		1.57M	2025-12
Danaher	USD 6.81B		483M	2025-12
Dentsply International	USD 1.34B		62M	2025-12
General Electric Aerospace	USD 38.98B		1.78B	2025-12
Henry Schein	USD 3.23B		79M	2025-12
Illumina	USD 1.59B		377M	2025-12
IQVIA Holdings	USD 8.34B		170M	2025-12
Mettler Toledo International	USD 1.2B		5.99M	2025-12
Myriad Genetics	USD 133.8M		14.2M	2025-12
OraSure Technologies	USD 39.8M		453K	2025-12
Pacific Biosciences Of California	USD 72.83M		9.62M	2025-12
Pfizer	USD 36.6B		1.13B	2025-09
Repligen	USD 135.83M		4.69M	2025-12
Revvity	USD 1.33B		108.5M	2025-12
Standard Biotools	USD 108.31M		343K	2025-12
Thermo Fisher Scientific	USD 15.19B		301M	2025-12
Waters	USD 1.24B		11.8M	2025-12
West Pharmaceutical Services	USD 654.9M		19.5M	2025-12